# Altaire Pharmaceuticals, Inc., Aquebogue, NY – FDA Inspections

Source: https://www.keypedia.com/companies/altaire-pharmaceuticals-inc/1e892910-1e24-4697-87c3-61cc48735f49

> Inspection records and compliance data for Altaire Pharmaceuticals, Inc. in Aquebogue, New York. 14 FDA inspections on record (2 OAI), 3 Form 483s, 1 warning letter, last inspected April 21, 2026.

---

## Details

- Name: Altaire Pharmaceuticals, Inc.
- FEI Number: 1000119582
- Business Operations: API MANUFACTURE, FDF MANUFACTURE
- Address Line 1: 311 W Ln
- City: Aquebogue
- State: New York
- Zip Code: 11931
- Country Name: United States
- Address: 311 W Ln, Aquebogue, New York 11931, United States
- Country: United States

## Related Documents

- 483 - Altaire Pharmaceuticals, Inc. - 2026-04-21 — source: FDA, date: April 21, 2026
- [FDA Inspection 1314330 - Altaire Pharmaceuticals, Inc. - 2026-04-21](https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/41e19a6e-ba33-47a8-ad24-842a94d518b4) — source: FDA, date: April 21, 2026
- FDA Inspection 1251507 - Altaire Pharmaceuticals, Inc. - 2024-10-21 — source: FDA, date: October 21, 2024
- FDA Inspection 1251507 - Altaire Pharmaceuticals, Inc. - 2024-10-21 — classification: No Action Indicated (NAI), source: FDA, date: October 21, 2024
- 483 - Altaire Pharmaceuticals, Inc. - 2022-02-11 — source: FDA, date: February 11, 2022
- [FDA Inspection 1162640 - Altaire Pharmaceuticals, Inc. - 2022-02-11](https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/0c20c70c-b178-4306-8b90-55ba5c3ee376) — classification: Official Action Indicated (OAI), source: FDA, date: February 11, 2022
- FDA Inspection 1162640 - Altaire Pharmaceuticals, Inc. - 2022-02-11 — classification: No Action Indicated (NAI), source: FDA, date: February 11, 2022
- [483 - Altaire Pharmaceuticals, Inc. - 2019-04-19](https://www.keypedia.com/records/483/altaire-pharmaceuticals-inc/17b1c45d-8f0f-4d45-b23c-7c3a31908c74) — source: FDA, date: April 19, 2019
- [WARNING_LETTER - Altaire Pharmaceuticals, Inc. - 2019-04-19](https://www.keypedia.com/records/warning_letter/altaire-pharmaceuticals-inc/ee7eb9fc-d9b3-4f35-a5bd-d29200e5854a) — source: FDA, date: April 19, 2019
- [FDA Inspection 1089315 - Altaire Pharmaceuticals, Inc. - 2019-04-19](https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/b7371309-8de4-43de-bec3-fb911cfa0240) — classification: Official Action Indicated (OAI), source: FDA, date: April 19, 2019
- FDA Inspection 1089315 - Altaire Pharmaceuticals, Inc. - 2019-04-19 — classification: Official Action Indicated (OAI), source: FDA, date: April 19, 2019
- FDA Inspection 1089315 - Altaire Pharmaceuticals, Inc. - 2019-04-19 — classification: Official Action Indicated (OAI), source: FDA, date: April 19, 2019
- [EIR - Altaire Pharmaceuticals, Inc. - 2017-03-09](https://www.keypedia.com/records/eir/altaire-pharmaceuticals-inc/6052c2c1-b665-4e59-8cfa-a1aa141ee60b) — source: FDA, date: March 9, 2017
- [483 - Altaire Pharmaceuticals, Inc. - 2017-03-09](https://www.keypedia.com/records/483/altaire-pharmaceuticals-inc/6f5a38e3-831e-43d0-8235-9fde10683ff0) — source: FDA, date: March 9, 2017
- [FDA Inspection 1005208 - Altaire Pharmaceuticals, Inc. - 2017-03-09](https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/f51d435b-4a99-4725-821e-eb2163b6329a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 9, 2017
- FDA Inspection 1005208 - Altaire Pharmaceuticals, Inc. - 2017-03-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 9, 2017

## Related Companies

- [King Bio Inc.](https://www.keypedia.com/companies/king-bio-inc/bad7278d-85cb-43ee-99a5-4cb9b13a45ea)
- [Sentio Biosciences LLC](https://www.keypedia.com/companies/sentio-biosciences-llc/82a36049-123a-40d5-8acd-c2027748dc10)
- [Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.](https://www.keypedia.com/companies/zhejiang-jinhua-conba-bio-pharm-co-ltd/ccf6fb2b-5de1-4f70-903b-d442374003f6)
- [Hisun Pharmaceutical Hangzhou Co., Ltd](https://www.keypedia.com/companies/hisun-pharmaceutical-hangzhou-co-ltd/08054db1-b8fe-4c18-8ee5-e6098cb2e427)
- [Regis Technologies, Inc.](https://www.keypedia.com/companies/regis-technologies-inc/b28a19bd-2caa-4023-9b89-ee609c032939)
- [Church & Dwight Co., Inc.](https://www.keypedia.com/companies/church-dwight-co-inc/d87194ae-f106-4ad7-9bc2-49ca798f781d)
- [Serumwerk Bernburg AG](https://www.keypedia.com/companies/serumwerk-bernburg-ag/b9464537-0d65-402a-a6cd-1a4d4b830a5b)
- [Les Importations Herbasante Inc.](https://www.keypedia.com/companies/les-importations-herbasante-inc/3d1eca38-4416-426d-a7ef-529d1e50ddf2)
- [Eastman Chemical Company](https://www.keypedia.com/companies/eastman-chemical-company/bd851c43-4385-4381-8bad-133ea397caf7)
- [MESSER LLC](https://www.keypedia.com/companies/messer-llc/3219d5fc-a54c-4b9d-b448-398e743b789a)

## Related Officers

- [Biotechnology Specialist at FDA](https://www.keypedia.com/people/robert-c-horan/81b78f43-200d-4eaa-a586-fe2101759ffd)
- [Avital Shimanovich](https://www.keypedia.com/people/avital-shimanovich/1417ebb4-da3a-4672-91ff-19d88cc26e23)
- [Bijoy Panicker](https://www.keypedia.com/people/bijoy-panicker/1c6ec57f-e02e-49b8-8b59-1853f3d2947a)
